![[Latest] Global Healthcare Discount Plan Market Size/Share Worth USD 48.37 Billion by 2035 at a 8.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://s.yimg.com/uu/api/res/1.2/JDc8Q43tjkZAOscxTVa7kA--~B/Zmk9c3RyaW07aD02Mzt3PTg0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/0bec09301614ea6a3ee415db83086891.cf.webp)
NasdaqGS - Delayed Quote
USD
GoodRx Holdings, Inc. (GDRX)
2.8500
+0.0500
(+1.79%)
At close: 4:00:01 PM EDT
2.8500
0.0000
(0.00%)
After hours: 4:04:53 PM EDT
Trade GDRX on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for GDRX
- Previous Close
2.8000 - Open
2.8300 - Bid 2.0400 x 200
- Ask 3.6200 x 200
- Day's Range
2.8001 - 2.8750 - 52 Week Range
1.7700 - 5.8100 - Volume
1,234,568 - Avg. Volume
1,525,122 - Market Cap (intraday)
965.225M - Beta (5Y Monthly) 1.62
- PE Ratio (TTM)
47.50 - EPS (TTM)
0.0600 - Earnings Date (est.) Aug 5, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.18
Recent News
View More
Performance Overview
Trailing total returns as of 6/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
GDRX
5.17%
S&P 500 (^GSPC)
8.69%
1-Year Return
GDRX
41.84%
S&P 500 (^GSPC)
20.53%
3-Year Return
GDRX
48.28%
S&P 500 (^GSPC)
69.24%
5-Year Return
GDRX
92.10%
S&P 500 (^GSPC)
73.36%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/26/2026
-
Market Cap
948.29M
-
Enterprise Value
1.25B
-
Trailing P/E
46.67
-
Forward P/E
5.44
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
1.23
-
Price/Book (mrq)
1.52
-
Enterprise Value/Revenue
1.59
-
Enterprise Value/EBITDA
7.23
Financial Highlights
Profitability and Income Statement
-
Profit Margin
2.61%
-
Return on Assets (ttm)
3.48%
-
Return on Equity (ttm)
3.22%
-
Revenue (ttm)
787.89M
-
Net Income Avi to Common (ttm)
20.56M
-
Diluted EPS (ttm)
0.0600
Balance Sheet and Cash Flow
-
Total Cash (mrq)
235.71M
-
Total Debt/Equity (mrq)
87.04%
-
Levered Free Cash Flow (ttm)
84.62M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Dropping Coverage of GoodRx
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
-
Placing GoodRx Under Review
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice Target -
GoodRx Shares Tumble After Full-Year Guidance Pulled on News of Grocer-PBMs Dispute
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice Target -
GoodRx Shares Tumble After Full-Year Guidance Pulled on News of Grocer-PBMs Dispute
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange for routing consumers to these discount programs, and separately through a subscription-based model (GoodRx Gold), which offers discounted drugs to customers paying a monthly membership fee.
RatingPrice Target
